secwatch.observer — SEC 8-K summary
======================================

Issuer:     Core Laboratories Inc. /DE/ (CLB)
CIK:        0001958086
Form:       8-K
Filed at:   2024-07-24T23:59:59+00:00
Accession:  0000950170-24-086092
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Core Labs Q2 revenue $130.6M; GAAP EPS $0.19, ex-items $0.22; cuts net debt $15.8M; declares $0.01 dividend
--------------------------------------------------------------------------------

- Revenue $130.6M, up slightly sequentially and YoY; operating income GAAP $16.0M, ex-items $16.4M (+10% sequentially, +5% YoY).
- GAAP EPS $0.19; ex-items EPS $0.22, up 16% sequentially and 5% YoY.
- Free cash flow $14.3M; net debt reduced by $15.8M during Q2 2024.
- Declares Q3 2024 dividend of $0.01/share, payable Aug 26, record Aug 5, 2024.
- Operating margins ex-items reached 13%, expanding over 100 bps sequentially.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958086/000095017024086092/0000950170-24-086092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958086/000095017024086092/clb-20240724.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-086092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer